BIOMAT Database Logo BIOMAT Database Logo

1-(2,3-Dideoxy-beta-D-glycero-pent-2-enofuranosyl)thymine. A highly potent and selective anti-HIV agent. 1989

M M Mansuri, and J E Starrett, and I Ghazzouli, and M J Hitchcock, and R Z Sterzycki, and V Brankovan, and T S Lin, and E M August, and W H Prusoff, and J P Sommadossi
Bristol-Myers Pharmaceutical Research and Development Division, Wallingford, Connecticut 06492-7660.

The nucleoside analogue 1-(2,3-dideoxy-beta-D-glycero-pent-2-enofuranosyl)thymine (d4T, 1) was prepared by ring opening of the 3',5'-anhydro compound 5. This method has been refined such that it can be used to prepare d4T on a large scale. The triphosphate of d4T was also synthesized from 1 in order to examine the mode of action. The in vitro inhibitory activity of d4T was found to be comparable to that of AZT in HIV-infected CEM cells. The triphosphate of d4T (8) and that of AZT inhibited the HIV reverse transcriptase with poly(rA):oligo(dT) as the template:primer with Ki values of 0.032 and 0.007 microM, respectively. The in vitro toxicity of d4T against normal human hematopoietic progenitor cells (CFU-GM) was measured in comparison to AZT. While d4T reduces colony-forming units by 50% at a concentration of 100 microM, it takes only 1 microM AZT to have a similar toxic effect. With erythrocyte burst forming units (BFU-E) the in vitro toxicities for d4T and AZT have comparable ID50 values of 10 and 6.7 microM, respectively.

UI MeSH Term Description Entries
D001853 Bone Marrow The soft tissue filling the cavities of bones. Bone marrow exists in two types, yellow and red. Yellow marrow is found in the large cavities of large bones and consists mostly of fat cells and a few primitive blood cells. Red marrow is a hematopoietic tissue and is the site of production of erythrocytes and granular leukocytes. Bone marrow is made up of a framework of connective tissue containing branching fibers with the frame being filled with marrow cells. Marrow,Red Marrow,Yellow Marrow,Marrow, Bone,Marrow, Red,Marrow, Yellow
D006678 HIV Human immunodeficiency virus. A non-taxonomic and historical term referring to any of two species, specifically HIV-1 and/or HIV-2. Prior to 1986, this was called human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). From 1986-1990, it was an official species called HIV. Since 1991, HIV was no longer considered an official species name; the two species were designated HIV-1 and HIV-2. AIDS Virus,HTLV-III,Human Immunodeficiency Viruses,Human T-Cell Lymphotropic Virus Type III,Human T-Lymphotropic Virus Type III,LAV-HTLV-III,Lymphadenopathy-Associated Virus,Acquired Immune Deficiency Syndrome Virus,Acquired Immunodeficiency Syndrome Virus,Human Immunodeficiency Virus,Human T Cell Lymphotropic Virus Type III,Human T Lymphotropic Virus Type III,Human T-Cell Leukemia Virus Type III,Immunodeficiency Virus, Human,Immunodeficiency Viruses, Human,Virus, Human Immunodeficiency,Viruses, Human Immunodeficiency,AIDS Viruses,Human T Cell Leukemia Virus Type III,Lymphadenopathy Associated Virus,Lymphadenopathy-Associated Viruses,Virus, AIDS,Virus, Lymphadenopathy-Associated,Viruses, AIDS,Viruses, Lymphadenopathy-Associated
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D013936 Thymidine A nucleoside in which THYMINE is linked to DEOXYRIBOSE. 2'-Deoxythymidine,Deoxythymidine,2' Deoxythymidine
D015215 Zidovudine A dideoxynucleoside compound in which the 3'-hydroxy group on the sugar moiety has been replaced by an azido group. This modification prevents the formation of phosphodiester linkages which are needed for the completion of nucleic acid chains. The compound is a potent inhibitor of HIV replication, acting as a chain-terminator of viral DNA during reverse transcription. It improves immunologic function, partially reverses the HIV-induced neurological dysfunction, and improves certain other clinical abnormalities associated with AIDS. Its principal toxic effect is dose-dependent suppression of bone marrow, resulting in anemia and leukopenia. AZT (Antiviral),Azidothymidine,3'-Azido-2',3'-Dideoxythymidine,3'-Azido-3'-deoxythymidine,AZT Antiviral,AZT, Antiviral,BW A509U,BWA-509U,Retrovir,3' Azido 2',3' Dideoxythymidine,3' Azido 3' deoxythymidine,Antiviral AZT,BWA 509U,BWA509U
D015224 Dideoxynucleosides Nucleosides that have two hydroxy groups removed from the sugar moiety. The majority of these compounds have broad-spectrum antiretroviral activity due to their action as antimetabolites. The nucleosides are phosphorylated intracellularly to their 5'-triphosphates and act as chain-terminating inhibitors of viral reverse transcription. 2',3'-Dideoxynucleosides,Dideoxyribonucleosides,ddNus,2',3' Dideoxynucleosides
D018119 Stavudine A dideoxynucleoside analog that inhibits reverse transcriptase and has in vitro activity against HIV. 2',3'-Didehydro-3'-deoxythymidine,D4T,2',3'-Didehydro-2',3'-dideoxythmidine,BMY-27857,Stavudine, Monosodium Salt,Zerit,2',3' Didehydro 3' deoxythymidine,BMY 27857,BMY27857

Related Publications

M M Mansuri, and J E Starrett, and I Ghazzouli, and M J Hitchcock, and R Z Sterzycki, and V Brankovan, and T S Lin, and E M August, and W H Prusoff, and J P Sommadossi
Synthesis of 1-(3-azido-2,3-dideoxy-beta-D-allofuranosyl)thymine, 1-(2,3-dideoxy-beta-D-allofuranosyl)thymine, and 1-(2,3-dideoxy-beta-D-erythro-hex-2-enofuranosyl)thymine.
September 1991, Carbohydrate research,
M M Mansuri, and J E Starrett, and I Ghazzouli, and M J Hitchcock, and R Z Sterzycki, and V Brankovan, and T S Lin, and E M August, and W H Prusoff, and J P Sommadossi
Synthesis of 9-(2,5-dideoxy-beta-D-glycero-pent-4-enofuranosyl)adenine.
October 1975, Carbohydrate research,
M M Mansuri, and J E Starrett, and I Ghazzouli, and M J Hitchcock, and R Z Sterzycki, and V Brankovan, and T S Lin, and E M August, and W H Prusoff, and J P Sommadossi
Preparation of the enantiomeric forms of 9-(5-deoxy-alpha-threo-pent-4-enofuranosyl)adenine and 9-(3,5-dideoxy-beta-D-glycero-pent-4-enofuranosyl)adenine and in vitro antileukemic screening.
January 1979, Journal of medicinal chemistry,
M M Mansuri, and J E Starrett, and I Ghazzouli, and M J Hitchcock, and R Z Sterzycki, and V Brankovan, and T S Lin, and E M August, and W H Prusoff, and J P Sommadossi
Antiviral activity and pharmacokinetics of 1-(2,3-dideoxy-2-fluoro-beta-L-glyceropent-2-enofuranosyl)cytosine.
June 2003, Antimicrobial agents and chemotherapy,
M M Mansuri, and J E Starrett, and I Ghazzouli, and M J Hitchcock, and R Z Sterzycki, and V Brankovan, and T S Lin, and E M August, and W H Prusoff, and J P Sommadossi
Unusual addition of amines to C-2 of vinyl sulfone-modified-beta-D-pent-2-enofuranosyl carbohydrates: synthesis of a new class of beta-anomeric 2-amino-2,3-dideoxy-D-threo-pentofuranosides.
June 2008, Carbohydrate research,
M M Mansuri, and J E Starrett, and I Ghazzouli, and M J Hitchcock, and R Z Sterzycki, and V Brankovan, and T S Lin, and E M August, and W H Prusoff, and J P Sommadossi
Preparation of the alpha and beta anomers of 9-(3,5-dideoxy-D-glycero-pent-4-enofuranosyl)adenine and their activity with leukemia L1210 cells in vitro.
July 1982, Journal of medicinal chemistry,
M M Mansuri, and J E Starrett, and I Ghazzouli, and M J Hitchcock, and R Z Sterzycki, and V Brankovan, and T S Lin, and E M August, and W H Prusoff, and J P Sommadossi
Isolation and characterization of an unsubstituted 2,3-unsaturated sugar, trans-2,3-dideoxy-D-glycero-pent-2-enose, produced by thermal dehydration of 2-deoxy-D-erythro-pentose.
October 1975, Carbohydrate research,
M M Mansuri, and J E Starrett, and I Ghazzouli, and M J Hitchcock, and R Z Sterzycki, and V Brankovan, and T S Lin, and E M August, and W H Prusoff, and J P Sommadossi
Glycosylation of nucleoside bases with 2,3-dideoxy-1-thio-D-glycero-pento-2-enofuranosides.
January 1995, Nucleic acids symposium series,
M M Mansuri, and J E Starrett, and I Ghazzouli, and M J Hitchcock, and R Z Sterzycki, and V Brankovan, and T S Lin, and E M August, and W H Prusoff, and J P Sommadossi
Synthesis of 5-chloro-1-(2,3-dideoxy-3-fluoro-beta-D-glycero-hex-2- enopyranose-4-ulosyl)uracil as potential anticancer/antiviral agent.
January 2001, Nucleosides, nucleotides & nucleic acids,
M M Mansuri, and J E Starrett, and I Ghazzouli, and M J Hitchcock, and R Z Sterzycki, and V Brankovan, and T S Lin, and E M August, and W H Prusoff, and J P Sommadossi
The synthesis of methyl 5-O-benzoyl-2,3-dideoxy-beta-D-glycero-pentofuranoside. IV. (Methyl 5-O-benzoyl-2,3-dideoxy-beta-D-ribofuranoside).
May 1967, Tetrahedron letters,
Copied contents to your clipboard!